Showing 3881-3890 of 5623 results for "".
- Oculus Incorporates New Subsidiary in Indiahttps://modernod.com/news/oculus-incorporates-new-subsidiary-in-india/2481614/Oculus has incorporated Oculus Medical Devices India as its 12th international subsidiary as of May 1, 2023. Located in Mumbai, Oculus India, aims to provide cutting-edge medical equipment to the Indian market while maintaining the high standards and quality that Oculus is known for. Sr
- Lumibird Medical Renames its Polish Subsidiary to Lumibird Medical Polskahttps://modernod.com/news/lumibird-medical-renames-its-polish-subsidiary-to-lumibird-medical-polska/2481613/Lumibird Medical Group has renamed its Polish subsidiary, Quantel Medical Polska, to Lumibird Medical Polska. After 5 years of existence, the Polish subsidiary, with a constant double-digit growth since its creation, has moved to a larger site in Warsaw. “
- New Museum of the Eye Exhibit Explores the Eye as a Cultural Symbol, From Ancient to Modern Timeshttps://modernod.com/news/new-museum-of-the-eye-exhibit-explores-the-eye-as-a-cultural-symbol-from-ancient-to-modern-times/2481612/Truhlsen-Marmor Museum of the Eye, the world’s only free, public museum dedicated to the science of sight, announced the opening of "Decoding the Eye: Signs and Symbols," a new exhibit exploring how the eye appears as a symbol throughout time. The exhibit will run from May 2023 to
- Eyenovia Receives FDA Approval of Mydcombi, the First Ophthalmic Spray for Mydriasishttps://modernod.com/news/eyenovia-receives-fda-approval-of-mydcombi-the-first-ophthalmic-spray-for-mydriasis/2481603/Eyenovia announced that the FDA has approved Mydcombi (tropicamide and phenylephrine hydrochloride ophthalmic spray) 1%/2.5% for inducing mydriasis for diagnostic procedures and in conditions where short term pupil dilation is desired. This represents the first approved fixed dose combinatio
- Norlase Receives FDA 510(k) Clearance and CE Mark Approval For ECHO Green Pattern Laserhttps://modernod.com/news/norlase-receives-fda-510k-clearance-and-ce-mark-approval-for-echo-green-pattern-laser/2481597/Norlase has received both FDA 510(k) clearance and CE Mark approval for the ECHO Green Pattern Laser photocoagulator. ECHO is a portable scanning laser photocoagulator utilizing MEMS technology. The laser and scanner are completely integrated into a single delivery device that
- Alcon Expands Plastic Bank Partnership in 2023 to Further Support Sustainability Effortshttps://modernod.com/news/alcon-expands-plastic-bank-partnership-in-2023-to-further-support-sustainability-efforts/2481591/Alcon announced the expansion of the partnership with Plastic Bank—an organization that builds recycling ecosystems in under-developed communities to fight plastic pollution while providing collection members with a path out of poverty. For each ton of plastic introduced in the marketp
- Sight Sciences' Glaucoma and Dry Eye Technologies to be Featured in Multiple Clinical Presentations at the 2023 ASCRShttps://modernod.com/news/sight-sciences-glaucoma-and-dry-eye-technologies-to-be-featured-in-multiple-clinical-presentations-at-the-2023-ascrs/2481590/Sight Sciences announced that two of its proprietary glaucoma and dry eye technologies, the Omni Surgical System and the TearCare System, will be featured in oral presentations and one poster at this year's ASCRS annual meeting in San Diego. The Omni Surgical System technology
- Harrow Launches Recently Acquired Products Ilevro, Nevanec, and Maxidex in the UShttps://modernod.com/news/harrow-launches-recently-acquired-products-ilevro-nevanec-and-maxidex-in-the-us/2481587/Harrow announced the completion of the transfer to Harrow of the new drug applications (NDAs) for Ilevro (nepafenac ophthalmic suspension) 0.3%, Nevanec (nepafenac ophthalmic suspension) 0.1%, and Maxidex (dexamethasone ophthalmic suspension) 0.1%. These three FDA-approved ophthalm
- Alcon Names Daniel M. Miller, MD, PhD, Senior Scientific Advisor to Alcon's R&D team PDFhttps://modernod.com/news/alcon-names-daniel-m-miller-md-phd-senior-scientific-advisor-to-alcons-rd-team-pdf/2481584/Alcon announced that the highly esteemed ophthalmologist, Daniel M. Miller, MD, PhD, will join Alcon as a member of the Research and Development (R&D) team. Dr. Miller is a fellowship-trained medical and surgical retina specialist. He will serve as a Senior Scientific Advisor to Alc
- BVI Completes Enrollment of Finevision HP IDE Clinical Studyhttps://modernod.com/news/bvi-completes-enrollment-of-finevision-hp-ide-clinical-study/2481581/BVI announced it has completed enrollment of its US Investigational Device Exemption (IDE) clinical study for its latest hydrophobic trifocal IOL, Finevision HP. The milestone marks the final implantation of the 539th patient enrolled in the prospective, multicenter, rand